The global market for Rheumatic Disorders Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rheumatic Disorders Treatment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Rheumatic Disorders Treatment by region & country, by Type, and by Application.

The Rheumatic Disorders Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatic Disorders Treatment.

Market Segmentation

Scope of Rheumatic Disorders Treatment - Market Report

Report Metric	Details
Report Name	Rheumatic Disorders Treatment - Market
CAGR	5%
Segment by Type:	Acts on TNF-α Acts on Interleukins and Interleukin Receptors Act on Protein Kinase Against Cell Surface Antigens Acts on Hormones and Hormone Receptors
Segment by Application	Hospital Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Humira, Enbrel, Simponi, Remicade, Rituxan, Stelara, Cosentyx, Prolia, Orencia, Actemra, Benlysta, Forteo
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Rheumatic Disorders Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Rheumatic Disorders Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Rheumatic Disorders Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Rheumatic Disorders Treatment - Market report?

Ans: The main players in the Rheumatic Disorders Treatment - Market are Humira, Enbrel, Simponi, Remicade, Rituxan, Stelara, Cosentyx, Prolia, Orencia, Actemra, Benlysta, Forteo

What are the Application segmentation covered in the Rheumatic Disorders Treatment - Market report?

Ans: The Applications covered in the Rheumatic Disorders Treatment - Market report are Hospital, Pharmacy, Other

What are the Type segmentation covered in the Rheumatic Disorders Treatment - Market report?

Ans: The Types covered in the Rheumatic Disorders Treatment - Market report are Acts on TNF-α, Acts on Interleukins and Interleukin Receptors, Act on Protein Kinase, Against Cell Surface Antigens, Acts on Hormones and Hormone Receptors

1 Market Overview

1.1 Rheumatic Disorders Treatment Product Introduction

1.2 Global Rheumatic Disorders Treatment Market Size Forecast

1.2.1 Global Rheumatic Disorders Treatment Sales Value (2019-2030)

1.2.2 Global Rheumatic Disorders Treatment Sales Volume (2019-2030)

1.2.3 Global Rheumatic Disorders Treatment Sales Price (2019-2030)

1.3 Rheumatic Disorders Treatment Market Trends & Drivers

1.3.1 Rheumatic Disorders Treatment Industry Trends

1.3.2 Rheumatic Disorders Treatment Market Drivers & Opportunity

1.3.3 Rheumatic Disorders Treatment Market Challenges

1.3.4 Rheumatic Disorders Treatment Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Rheumatic Disorders Treatment Players Revenue Ranking (2023)

2.2 Global Rheumatic Disorders Treatment Revenue by Company (2019-2024)

2.3 Global Rheumatic Disorders Treatment Players Sales Volume Ranking (2023)

2.4 Global Rheumatic Disorders Treatment Sales Volume by Company Players (2019-2024)

2.5 Global Rheumatic Disorders Treatment Average Price by Company (2019-2024)

2.6 Key Manufacturers Rheumatic Disorders Treatment Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Rheumatic Disorders Treatment Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Rheumatic Disorders Treatment

2.9 Rheumatic Disorders Treatment Market Competitive Analysis

2.9.1 Rheumatic Disorders Treatment Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Rheumatic Disorders Treatment Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatic Disorders Treatment as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Acts on TNF-α

3.1.2 Acts on Interleukins and Interleukin Receptors

3.1.3 Act on Protein Kinase

3.1.4 Against Cell Surface Antigens

3.1.5 Acts on Hormones and Hormone Receptors

3.2 Global Rheumatic Disorders Treatment Sales Value by Type

3.2.1 Global Rheumatic Disorders Treatment Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Rheumatic Disorders Treatment Sales Value, by Type (2019-2030)

3.2.3 Global Rheumatic Disorders Treatment Sales Value, by Type (%) (2019-2030)

3.3 Global Rheumatic Disorders Treatment Sales Volume by Type

3.3.1 Global Rheumatic Disorders Treatment Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Rheumatic Disorders Treatment Sales Volume, by Type (2019-2030)

3.3.3 Global Rheumatic Disorders Treatment Sales Volume, by Type (%) (2019-2030)

3.4 Global Rheumatic Disorders Treatment Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Pharmacy

4.1.3 Other

4.2 Global Rheumatic Disorders Treatment Sales Value by Application

4.2.1 Global Rheumatic Disorders Treatment Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Rheumatic Disorders Treatment Sales Value, by Application (2019-2030)

4.2.3 Global Rheumatic Disorders Treatment Sales Value, by Application (%) (2019-2030)

4.3 Global Rheumatic Disorders Treatment Sales Volume by Application

4.3.1 Global Rheumatic Disorders Treatment Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Rheumatic Disorders Treatment Sales Volume, by Application (2019-2030)

4.3.3 Global Rheumatic Disorders Treatment Sales Volume, by Application (%) (2019-2030)

4.4 Global Rheumatic Disorders Treatment Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Rheumatic Disorders Treatment Sales Value by Region

5.1.1 Global Rheumatic Disorders Treatment Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Rheumatic Disorders Treatment Sales Value by Region (2019-2024)

5.1.3 Global Rheumatic Disorders Treatment Sales Value by Region (2025-2030)

5.1.4 Global Rheumatic Disorders Treatment Sales Value by Region (%), (2019-2030)

5.2 Global Rheumatic Disorders Treatment Sales Volume by Region

5.2.1 Global Rheumatic Disorders Treatment Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Rheumatic Disorders Treatment Sales Volume by Region (2019-2024)

5.2.3 Global Rheumatic Disorders Treatment Sales Volume by Region (2025-2030)

5.2.4 Global Rheumatic Disorders Treatment Sales Volume by Region (%), (2019-2030)

5.3 Global Rheumatic Disorders Treatment Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Rheumatic Disorders Treatment Sales Value, 2019-2030

5.4.2 North America Rheumatic Disorders Treatment Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Rheumatic Disorders Treatment Sales Value, 2019-2030

5.5.2 Europe Rheumatic Disorders Treatment Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Rheumatic Disorders Treatment Sales Value, 2019-2030

5.6.2 Asia Pacific Rheumatic Disorders Treatment Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Rheumatic Disorders Treatment Sales Value, 2019-2030

5.7.2 South America Rheumatic Disorders Treatment Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Rheumatic Disorders Treatment Sales Value, 2019-2030

5.8.2 Middle East & Africa Rheumatic Disorders Treatment Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Rheumatic Disorders Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Rheumatic Disorders Treatment Sales Value

6.2.1 Key Countries/Regions Rheumatic Disorders Treatment Sales Value, 2019-2030

6.2.2 Key Countries/Regions Rheumatic Disorders Treatment Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Rheumatic Disorders Treatment Sales Value, 2019-2030

6.3.2 United States Rheumatic Disorders Treatment Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Rheumatic Disorders Treatment Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Rheumatic Disorders Treatment Sales Value, 2019-2030

6.4.2 Europe Rheumatic Disorders Treatment Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Rheumatic Disorders Treatment Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Rheumatic Disorders Treatment Sales Value, 2019-2030

6.5.2 China Rheumatic Disorders Treatment Sales Value by Type (%), 2023 VS 2030

6.5.3 China Rheumatic Disorders Treatment Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Rheumatic Disorders Treatment Sales Value, 2019-2030

6.6.2 Japan Rheumatic Disorders Treatment Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Rheumatic Disorders Treatment Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Rheumatic Disorders Treatment Sales Value, 2019-2030

6.7.2 South Korea Rheumatic Disorders Treatment Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Rheumatic Disorders Treatment Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Rheumatic Disorders Treatment Sales Value, 2019-2030

6.8.2 Southeast Asia Rheumatic Disorders Treatment Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Rheumatic Disorders Treatment Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Rheumatic Disorders Treatment Sales Value, 2019-2030

6.9.2 India Rheumatic Disorders Treatment Sales Value by Type (%), 2023 VS 2030

6.9.3 India Rheumatic Disorders Treatment Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Humira

7.1.1 Humira Company Information

7.1.2 Humira Introduction and Business Overview

7.1.3 Humira Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Humira Rheumatic Disorders Treatment Product Offerings

7.1.5 Humira Recent Development

7.2 Enbrel

7.2.1 Enbrel Company Information

7.2.2 Enbrel Introduction and Business Overview

7.2.3 Enbrel Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Enbrel Rheumatic Disorders Treatment Product Offerings

7.2.5 Enbrel Recent Development

7.3 Simponi

7.3.1 Simponi Company Information

7.3.2 Simponi Introduction and Business Overview

7.3.3 Simponi Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Simponi Rheumatic Disorders Treatment Product Offerings

7.3.5 Simponi Recent Development

7.4 Remicade

7.4.1 Remicade Company Information

7.4.2 Remicade Introduction and Business Overview

7.4.3 Remicade Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Remicade Rheumatic Disorders Treatment Product Offerings

7.4.5 Remicade Recent Development

7.5 Rituxan

7.5.1 Rituxan Company Information

7.5.2 Rituxan Introduction and Business Overview

7.5.3 Rituxan Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Rituxan Rheumatic Disorders Treatment Product Offerings

7.5.5 Rituxan Recent Development

7.6 Stelara

7.6.1 Stelara Company Information

7.6.2 Stelara Introduction and Business Overview

7.6.3 Stelara Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Stelara Rheumatic Disorders Treatment Product Offerings

7.6.5 Stelara Recent Development

7.7 Cosentyx

7.7.1 Cosentyx Company Information

7.7.2 Cosentyx Introduction and Business Overview

7.7.3 Cosentyx Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Cosentyx Rheumatic Disorders Treatment Product Offerings

7.7.5 Cosentyx Recent Development

7.8 Prolia

7.8.1 Prolia Company Information

7.8.2 Prolia Introduction and Business Overview

7.8.3 Prolia Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Prolia Rheumatic Disorders Treatment Product Offerings

7.8.5 Prolia Recent Development

7.9 Orencia

7.9.1 Orencia Company Information

7.9.2 Orencia Introduction and Business Overview

7.9.3 Orencia Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Orencia Rheumatic Disorders Treatment Product Offerings

7.9.5 Orencia Recent Development

7.10 Actemra

7.10.1 Actemra Company Information

7.10.2 Actemra Introduction and Business Overview

7.10.3 Actemra Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Actemra Rheumatic Disorders Treatment Product Offerings

7.10.5 Actemra Recent Development

7.11 Benlysta

7.11.1 Benlysta Company Information

7.11.2 Benlysta Introduction and Business Overview

7.11.3 Benlysta Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Benlysta Rheumatic Disorders Treatment Product Offerings

7.11.5 Benlysta Recent Development

7.12 Forteo

7.12.1 Forteo Company Information

7.12.2 Forteo Introduction and Business Overview

7.12.3 Forteo Rheumatic Disorders Treatment Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Forteo Rheumatic Disorders Treatment Product Offerings

7.12.5 Forteo Recent Development

8 Industry Chain Analysis

8.1 Rheumatic Disorders Treatment Industrial Chain

8.2 Rheumatic Disorders Treatment Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Rheumatic Disorders Treatment Sales Model

8.5.2 Sales Channel

8.5.3 Rheumatic Disorders Treatment Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Rheumatic Disorders Treatment Market Trends

Table 2. Rheumatic Disorders Treatment Market Drivers & Opportunity

Table 3. Rheumatic Disorders Treatment Market Challenges

Table 4. Rheumatic Disorders Treatment Market Restraints

Table 5. Global Rheumatic Disorders Treatment Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Rheumatic Disorders Treatment Revenue Market Share by Company (2019-2024)

Table 7. Global Rheumatic Disorders Treatment Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Rheumatic Disorders Treatment Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Rheumatic Disorders Treatment Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Rheumatic Disorders Treatment Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Rheumatic Disorders Treatment Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Rheumatic Disorders Treatment

Table 13. Global Rheumatic Disorders Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatic Disorders Treatment as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Rheumatic Disorders Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Rheumatic Disorders Treatment Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Rheumatic Disorders Treatment Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Rheumatic Disorders Treatment Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Rheumatic Disorders Treatment Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Rheumatic Disorders Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Rheumatic Disorders Treatment Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Rheumatic Disorders Treatment Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Rheumatic Disorders Treatment Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Rheumatic Disorders Treatment Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Rheumatic Disorders Treatment Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Rheumatic Disorders Treatment Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Rheumatic Disorders Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Rheumatic Disorders Treatment Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Rheumatic Disorders Treatment Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Rheumatic Disorders Treatment Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Rheumatic Disorders Treatment Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Rheumatic Disorders Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Rheumatic Disorders Treatment Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Rheumatic Disorders Treatment Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Rheumatic Disorders Treatment Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Rheumatic Disorders Treatment Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Rheumatic Disorders Treatment Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Rheumatic Disorders Treatment Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Rheumatic Disorders Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Rheumatic Disorders Treatment Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Rheumatic Disorders Treatment Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Rheumatic Disorders Treatment Sales Value by Region (2019-2024) & (%)

Table 44. Global Rheumatic Disorders Treatment Sales Value by Region (2025-2030) & (%)

Table 45. Global Rheumatic Disorders Treatment Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Rheumatic Disorders Treatment Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Rheumatic Disorders Treatment Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Rheumatic Disorders Treatment Sales Volume by Region (2019-2024) & (%)

Table 49. Global Rheumatic Disorders Treatment Sales Volume by Region (2025-2030) & (%)

Table 50. Global Rheumatic Disorders Treatment Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Rheumatic Disorders Treatment Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Rheumatic Disorders Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Rheumatic Disorders Treatment Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Rheumatic Disorders Treatment Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Rheumatic Disorders Treatment Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Rheumatic Disorders Treatment Sales Volume, (2025-2030) & (K Units)

Table 57. Humira Company Information

Table 58. Humira Introduction and Business Overview

Table 59. Humira Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Humira Rheumatic Disorders Treatment Product Offerings

Table 61. Humira Recent Development

Table 62. Enbrel Company Information

Table 63. Enbrel Introduction and Business Overview

Table 64. Enbrel Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Enbrel Rheumatic Disorders Treatment Product Offerings

Table 66. Enbrel Recent Development

Table 67. Simponi Company Information

Table 68. Simponi Introduction and Business Overview

Table 69. Simponi Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Simponi Rheumatic Disorders Treatment Product Offerings

Table 71. Simponi Recent Development

Table 72. Remicade Company Information

Table 73. Remicade Introduction and Business Overview

Table 74. Remicade Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Remicade Rheumatic Disorders Treatment Product Offerings

Table 76. Remicade Recent Development

Table 77. Rituxan Company Information

Table 78. Rituxan Introduction and Business Overview

Table 79. Rituxan Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Rituxan Rheumatic Disorders Treatment Product Offerings

Table 81. Rituxan Recent Development

Table 82. Stelara Company Information

Table 83. Stelara Introduction and Business Overview

Table 84. Stelara Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Stelara Rheumatic Disorders Treatment Product Offerings

Table 86. Stelara Recent Development

Table 87. Cosentyx Company Information

Table 88. Cosentyx Introduction and Business Overview

Table 89. Cosentyx Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Cosentyx Rheumatic Disorders Treatment Product Offerings

Table 91. Cosentyx Recent Development

Table 92. Prolia Company Information

Table 93. Prolia Introduction and Business Overview

Table 94. Prolia Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Prolia Rheumatic Disorders Treatment Product Offerings

Table 96. Prolia Recent Development

Table 97. Orencia Company Information

Table 98. Orencia Introduction and Business Overview

Table 99. Orencia Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Orencia Rheumatic Disorders Treatment Product Offerings

Table 101. Orencia Recent Development

Table 102. Actemra Company Information

Table 103. Actemra Introduction and Business Overview

Table 104. Actemra Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Actemra Rheumatic Disorders Treatment Product Offerings

Table 106. Actemra Recent Development

Table 107. Benlysta Company Information

Table 108. Benlysta Introduction and Business Overview

Table 109. Benlysta Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Benlysta Rheumatic Disorders Treatment Product Offerings

Table 111. Benlysta Recent Development

Table 112. Forteo Company Information

Table 113. Forteo Introduction and Business Overview

Table 114. Forteo Rheumatic Disorders Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Forteo Rheumatic Disorders Treatment Product Offerings

Table 116. Forteo Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Rheumatic Disorders Treatment Downstream Customers

Table 120. Rheumatic Disorders Treatment Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Rheumatic Disorders Treatment Product Picture

Figure 2. Global Rheumatic Disorders Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Rheumatic Disorders Treatment Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Rheumatic Disorders Treatment Sales Volume (2019-2030) & (K Units)

Figure 5. Global Rheumatic Disorders Treatment Sales Price (2019-2030) & (US$/Unit)

Figure 6. Rheumatic Disorders Treatment Report Years Considered

Figure 7. Global Rheumatic Disorders Treatment Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Rheumatic Disorders Treatment Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Rheumatic Disorders Treatment Revenue in 2023

Figure 10. Rheumatic Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Acts on TNF-α Picture

Figure 12. Acts on Interleukins and Interleukin Receptors Picture

Figure 13. Act on Protein Kinase Picture

Figure 14. Against Cell Surface Antigens Picture

Figure 15. Acts on Hormones and Hormone Receptors Picture

Figure 16. Global Rheumatic Disorders Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Rheumatic Disorders Treatment Sales Value Market Share by Type, 2023 & 2030

Figure 18. Global Rheumatic Disorders Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 19. Global Rheumatic Disorders Treatment Sales Volume Market Share by Type, 2023 & 2030

Figure 20. Global Rheumatic Disorders Treatment Price by Type (2019-2030) & (US$/Unit)

Figure 21. Product Picture of Hospital

Figure 22. Product Picture of Pharmacy

Figure 23. Product Picture of Other

Figure 24. Global Rheumatic Disorders Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global Rheumatic Disorders Treatment Sales Value Market Share by Application, 2023 & 2030

Figure 26. Global Rheumatic Disorders Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 27. Global Rheumatic Disorders Treatment Sales Volume Market Share by Application, 2023 & 2030

Figure 28. Global Rheumatic Disorders Treatment Price by Application (2019-2030) & (US$/Unit)

Figure 29. North America Rheumatic Disorders Treatment Sales Value (2019-2030) & (US$ Million)

Figure 30. North America Rheumatic Disorders Treatment Sales Value by Country (%), 2023 VS 2030

Figure 31. Europe Rheumatic Disorders Treatment Sales Value (2019-2030) & (US$ Million)

Figure 32. Europe Rheumatic Disorders Treatment Sales Value by Country (%), 2023 VS 2030

Figure 33. Asia Pacific Rheumatic Disorders Treatment Sales Value (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Rheumatic Disorders Treatment Sales Value by Country (%), 2023 VS 2030

Figure 35. South America Rheumatic Disorders Treatment Sales Value (2019-2030) & (US$ Million)

Figure 36. South America Rheumatic Disorders Treatment Sales Value by Country (%), 2023 VS 2030

Figure 37. Middle East & Africa Rheumatic Disorders Treatment Sales Value (2019-2030) & (US$ Million)

Figure 38. Middle East & Africa Rheumatic Disorders Treatment Sales Value by Country (%), 2023 VS 2030

Figure 39. Key Countries/Regions Rheumatic Disorders Treatment Sales Value (%), (2019-2030)

Figure 40. Key Countries/Regions Rheumatic Disorders Treatment Sales Volume (%), (2019-2030)

Figure 41. United States Rheumatic Disorders Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 42. United States Rheumatic Disorders Treatment Sales Value by Type (%), 2023 VS 2030

Figure 43. United States Rheumatic Disorders Treatment Sales Value by Application (%), 2023 VS 2030

Figure 44. Europe Rheumatic Disorders Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 45. Europe Rheumatic Disorders Treatment Sales Value by Type (%), 2023 VS 2030

Figure 46. Europe Rheumatic Disorders Treatment Sales Value by Application (%), 2023 VS 2030

Figure 47. China Rheumatic Disorders Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 48. China Rheumatic Disorders Treatment Sales Value by Type (%), 2023 VS 2030

Figure 49. China Rheumatic Disorders Treatment Sales Value by Application (%), 2023 VS 2030

Figure 50. Japan Rheumatic Disorders Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 51. Japan Rheumatic Disorders Treatment Sales Value by Type (%), 2023 VS 2030

Figure 52. Japan Rheumatic Disorders Treatment Sales Value by Application (%), 2023 VS 2030

Figure 53. South Korea Rheumatic Disorders Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 54. South Korea Rheumatic Disorders Treatment Sales Value by Type (%), 2023 VS 2030

Figure 55. South Korea Rheumatic Disorders Treatment Sales Value by Application (%), 2023 VS 2030

Figure 56. Southeast Asia Rheumatic Disorders Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 57. Southeast Asia Rheumatic Disorders Treatment Sales Value by Type (%), 2023 VS 2030

Figure 58. Southeast Asia Rheumatic Disorders Treatment Sales Value by Application (%), 2023 VS 2030

Figure 59. India Rheumatic Disorders Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 60. India Rheumatic Disorders Treatment Sales Value by Type (%), 2023 VS 2030

Figure 61. India Rheumatic Disorders Treatment Sales Value by Application (%), 2023 VS 2030

Figure 62. Rheumatic Disorders Treatment Industrial Chain

Figure 63. Rheumatic Disorders Treatment Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Rheumatoid Arthritis Testing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33E11182

Thu Oct 17 00:00:00 UTC 2024

Add to Cart

Rheumatic Disorders Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-15X13281

Mon Oct 14 00:00:00 UTC 2024

Add to Cart

Rheumatology Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-29B5986

Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Rheumatology Arthritis Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-1J13864

Sat Oct 05 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions